Nifty

:

24718.60

Sensex

:

81118.60

-169.60 (-0.68%)
-573.38 (-0.70%)

Login

Nifty
Sensex

:
:

24718.60
81118.60

-169.60 (-0.68%)
-573.38 (-0.70%)

Remedium Lifecare Ltd.

Trading

Rating :

N/A

BSE: 539561 | NSE: Not Listed

Watchlist

NSE BSE

1.09

13-Jun-2025

Open
High
Low
Previous Close

1.09
1.18
1.09
1.14

Volume
Traded Value (lacs)
52 Week High
52 Week Low

73651243
80353341
1.18
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

96.14
62.83
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,236.17
N/A
1.05

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

112.83
325.73
100.06

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
144.68
80.00

PAT CAGR (%)

10 Years
5 Years
3 Years

49.42
159.15
211.77

P:E (Median)

8 Years
5 Years
3 Years

-
26.64
15.85

P:BV (Average)

8 Years
5 Years
3 Years

-
17.53
24.07

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
39.35
38.74

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 81.57 1,408.49 -94.21% 38.15 1,834.18 -97.92% 25.08 468.57 -94.65% 77.70 330.47 -76.49%
Expenses 82.75 1,443.52 -94.27% 43.63 1,779.48 -97.55% 20.62 462.23 -95.54% 77.31 323.18 -76.08%
EBITDA -1.18 -35.03 - -5.48 54.70 - 4.46 6.34 -29.65% 0.38 7.28 -94.78%
EBIDTM -1.44% -2.49% -14.36% 2.98% 17.78% 1.35% 0.50% 2.20%
Other Income 0.66 2.89 -77.16% 7.43 14.12 -47.38% 0.82 4.08 -79.90% 1.89 0.00 0
Interest 1.59 3.85 -58.70% 0.88 0.03 2,833.33% 2.81 0.00 0 0.00 0.00 0
Depreciation 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.02 -50.00% 0.01 0.01 0.00%
PBT -2.12 -36.00 - 1.06 68.78 -98.46% 2.46 10.40 -76.35% 2.26 7.27 -68.91%
Tax 0.52 17.72 -97.07% 0.30 22.96 -98.69% 0.68 3.88 -82.47% 0.63 2.02 -68.81%
PAT -2.64 -53.72 - 0.76 45.82 -98.34% 1.77 6.53 -72.89% 1.64 5.25 -68.76%
PATM -3.24% -3.81% 2.00% 2.50% 7.08% 1.39% 2.10% 1.59%
EPS -0.07 -1.33 - 0.02 1.14 -98.25% 0.04 0.16 -75.00% 0.04 0.13 -69.23%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 264.32 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 264.78 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA -0.46 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM -0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.66 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 1.59 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.01 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT -1.40 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.65 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -2.05 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM -0.77% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS -0.04 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 222.50 4,041.71 509.84 504.79 90.03 2.89 0.16 0.35 1.33 3.93 2.12 Net Sales Growth -94.49% 692.74% 1.00% 460.69% 3015.22% 1706.25% -54.29% -73.68% -66.16% 85.38% Cost Of Goods Sold 216.11 4,001.37 493.85 498.47 87.74 1.67 0.05 0.14 0.46 3.38 1.85 Gross Profit 6.39 40.33 15.98 6.32 2.29 1.22 0.11 0.21 0.87 0.55 0.26 GP Margin 2.87% 1.00% 3.13% 1.25% 2.54% 42.21% 68.75% 60.0% 65.41% 13.99% 12.26% Total Expenditure 224.31 4,007.51 502.67 502.98 89.31 2.50 0.23 0.35 1.43 4.23 2.29 Power & Fuel Cost - 0.06 0.06 0.09 0.07 0.00 0.01 0.02 0.08 0.08 0.06 % Of Sales - 0.00% 0.01% 0.02% 0.08% 0% 6.25% 5.71% 6.02% 2.04% 2.83% Employee Cost - 0.40 0.55 0.21 0.19 0.18 0.04 0.13 0.04 0.05 0.11 % Of Sales - 0.01% 0.11% 0.04% 0.21% 6.23% 25.00% 37.14% 3.01% 1.27% 5.19% Manufacturing Exp. - 0.95 1.68 1.64 0.14 0.00 0.00 0.00 0.71 0.50 0.15 % Of Sales - 0.02% 0.33% 0.32% 0.16% 0% 0% 0% 53.38% 12.72% 7.08% General & Admin Exp. - 2.63 4.82 2.06 1.13 0.64 0.12 0.05 0.13 0.20 0.09 % Of Sales - 0.07% 0.95% 0.41% 1.26% 22.15% 75.00% 14.29% 9.77% 5.09% 4.25% Selling & Distn. Exp. - 1.90 0.03 0.32 0.04 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.05% 0.01% 0.06% 0.04% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 0.20 1.67 0.19 0.00 0.00 0.01 0.01 0.01 0.01 0.00 % Of Sales - 0.00% 0.33% 0.04% 0% 0% 6.25% 2.86% 0.75% 0.25% 0.47% EBITDA -1.82 34.20 7.17 1.81 0.72 0.39 -0.07 0.00 -0.10 -0.30 -0.17 EBITDA Margin -0.82% 0.85% 1.41% 0.36% 0.80% 13.49% -43.75% 0% -7.52% -7.63% -8.02% Other Income 10.80 21.10 0.83 0.01 0.01 0.00 0.09 0.02 0.10 0.33 0.91 Interest 5.28 4.78 0.45 0.23 0.02 0.00 0.00 0.00 0.00 0.01 0.00 Depreciation 0.04 0.06 0.15 0.07 0.06 0.01 0.00 0.00 0.00 0.01 0.01 PBT 3.66 50.45 7.40 1.53 0.65 0.38 0.02 0.02 0.00 0.01 0.73 Tax 2.13 17.72 1.97 0.45 0.17 0.10 0.01 0.00 0.00 0.00 0.14 Tax Rate 58.20% 35.12% 26.62% 29.41% 26.15% 26.32% 50.00% 0.00% 0.00% 0.00% 19.18% PAT 1.53 32.73 5.43 1.08 0.48 0.28 0.01 0.01 0.00 0.01 0.59 PAT before Minority Interest 1.53 32.73 5.43 1.08 0.48 0.28 0.01 0.01 0.00 0.01 0.59 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.69% 0.81% 1.07% 0.21% 0.53% 9.69% 6.25% 2.86% 0% 0.25% 27.83% PAT Growth -60.57% 502.76% 402.78% 125.00% 71.43% 2,700.00% 0.00% 0 -100.00% -98.31% EPS 0.04 0.81 0.13 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.01

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 42.96 10.36 4.94 3.86 3.35 3.08 3.07 3.04 3.04 3.04 Share Capital 10.08 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.60 Total Reserves 32.88 6.76 1.34 0.26 -0.25 -0.52 -0.53 -0.56 -0.56 -0.56 Non-Current Liabilities -0.03 -0.01 0.00 10.50 0.37 0.08 -0.01 0.00 0.00 0.10 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Unsecured Loans 0.00 0.00 0.00 10.50 0.36 0.08 0.00 0.00 0.00 0.05 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 1,904.97 1,143.86 218.82 24.17 0.55 0.37 0.07 0.26 1.53 2.70 Trade Payables 712.29 84.22 124.56 23.77 0.39 0.35 0.00 0.00 1.37 2.40 Other Current Liabilities 1,116.70 1,057.13 93.79 0.25 0.00 0.00 0.06 0.23 0.16 0.15 Short Term Borrowings 57.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 18.27 2.51 0.47 0.15 0.16 0.02 0.00 0.03 0.00 0.14 Total Liabilities 1,947.90 1,154.21 223.76 38.53 4.27 3.53 3.13 3.30 4.57 5.84 Net Block 0.05 0.08 0.19 0.21 0.23 0.00 0.01 0.01 0.02 1.43 Gross Block 0.22 0.20 0.34 0.29 0.24 0.00 0.21 0.21 0.21 1.93 Accumulated Depreciation 0.18 0.12 0.15 0.08 0.01 0.00 0.20 0.19 0.19 0.50 Non Current Assets 0.05 0.08 0.19 0.21 0.23 0.00 0.97 0.96 0.87 2.50 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.95 0.95 0.86 1.07 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 Current Assets 1,947.85 1,154.14 223.57 38.32 4.04 3.53 2.16 2.33 3.70 3.33 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 133.23 7.32 83.87 3.11 0.70 0.20 0.00 0.00 0.83 1.33 Sundry Debtors 920.60 172.37 64.00 23.68 1.50 0.14 2.03 2.17 2.85 1.98 Cash & Bank 1.52 21.86 1.44 0.81 0.93 1.08 0.02 0.16 0.01 0.01 Other Current Assets 892.49 1.26 1.73 0.35 0.91 2.11 0.11 0.00 0.01 0.01 Short Term Loans & Adv. 889.18 951.33 72.54 10.37 0.91 2.11 0.11 0.00 0.01 0.01 Net Current Assets 42.88 10.28 4.75 14.15 3.49 3.15 2.09 2.08 2.17 0.63 Total Assets 1,947.90 1,154.22 223.76 38.53 4.27 3.53 3.13 3.29 4.57 5.83

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -74.16 20.50 11.28 -10.21 -0.20 -0.07 -0.16 0.07 -1.36 0.09 PBT 50.45 7.40 1.53 0.65 0.38 0.01 0.02 0.00 0.01 0.73 Adjustment 3.84 0.19 0.18 0.06 0.01 -0.09 0.00 -0.09 -0.05 -0.08 Changes in Working Capital -110.64 14.89 10.03 -10.89 -0.59 0.00 -0.17 0.15 -1.32 -0.55 Cash after chg. in Working capital -56.35 22.48 11.73 -10.17 -0.20 -0.08 -0.16 0.07 -1.36 0.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -17.81 -1.98 -0.45 -0.04 0.00 0.01 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.09 -0.04 -0.05 -0.04 -0.24 1.06 0.02 0.09 1.48 0.10 Net Fixed Assets -0.02 0.14 -0.05 -0.05 -0.24 0.21 0.00 0.00 1.72 0.09 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.11 -0.18 0.00 0.01 0.00 0.85 0.02 0.09 -0.24 0.01 Cash from Financing Activity 53.74 -0.04 -10.61 10.14 0.29 0.08 0.00 0.00 -0.11 -0.24 Net Cash Inflow / Outflow -20.33 20.42 0.62 -0.11 -0.15 1.06 -0.14 0.15 0.00 -0.05 Opening Cash & Equivalents 21.86 1.44 0.81 0.93 1.08 0.02 0.16 0.01 0.01 0.19 Closing Cash & Equivalent 1.52 21.86 1.44 0.81 0.93 1.08 0.02 0.16 0.01 0.14

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 0.74 0.26 2.45 10.72 9.32 8.55 8.52 8.44 8.45 8.43 ROA 2.11% 0.79% 0.82% 2.25% 7.11% 0.24% 0.42% 0.09% 0.21% 8.92% ROE 122.76% 70.92% 24.51% 13.33% 8.62% 0.26% 0.45% 0.11% 0.36% 21.40% ROCE 99.51% 102.54% 18.16% 7.39% 10.92% 0.62% 0.55% 0.14% 0.66% 24.60% Fixed Asset Turnover 0.00 1909.86 1621.56 339.30 11.83 0.00 1.68 6.41 3.67 1.07 Receivable days 49.35 84.61 31.70 51.05 103.36 2487.09 2189.19 687.52 224.29 383.18 Inventory Days 6.35 32.64 31.45 7.72 57.20 469.61 0.00 0.00 100.49 279.87 Payable days 36.33 77.15 54.31 50.25 72.12 677.17 0.00 0.00 0.00 0.00 Cash Conversion Cycle 19.37 40.10 8.84 8.52 88.44 2279.54 2189.19 687.52 324.78 663.05 Total Debt/Equity 1.34 0.00 0.00 2.72 0.11 0.02 0.00 0.00 0.00 0.03 Interest Cover 11.55 17.46 7.72 43.12 0.00 193.00 84.50 14.11 2.18 1032.24

Annual Reports:

News Update:

Remedium Lifecare’s arm partners with JiyaYu Lifesciences
9th May 2025, 10:00 AM

JiyaYu Lifesciences will license out fully developed and scalable technologies to Remlife Global on an exclusive basis
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback